Champions Oncology Inc (CSBR)
4.85
-0.07
(-1.42%)
USD |
NASDAQ |
Apr 30, 16:00
Champions Oncology Max Drawdown (5Y): 78.53% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 78.53% |
| March 31, 2024 | 78.53% |
| February 29, 2024 | 78.53% |
| January 31, 2024 | 78.53% |
| December 31, 2023 | 78.53% |
| November 30, 2023 | 78.53% |
| October 31, 2023 | 78.53% |
| September 30, 2023 | 78.53% |
| August 31, 2023 | 78.53% |
| July 31, 2023 | 78.53% |
| June 30, 2023 | 78.53% |
| May 31, 2023 | 78.53% |
| April 30, 2023 | 78.53% |
| March 31, 2023 | 78.53% |
| February 28, 2023 | 82.59% |
| January 31, 2023 | 84.21% |
| December 31, 2022 | 84.74% |
| November 30, 2022 | 85.13% |
| October 31, 2022 | 85.13% |
| September 30, 2022 | 85.13% |
| August 31, 2022 | 85.92% |
| July 31, 2022 | 86.10% |
| June 30, 2022 | 86.62% |
| May 31, 2022 | 87.15% |
| April 30, 2022 | 88.99% |
| Date | Value |
|---|---|
| March 31, 2022 | 89.78% |
| February 28, 2022 | 89.78% |
| January 31, 2022 | 89.78% |
| December 31, 2021 | 89.78% |
| November 30, 2021 | 89.78% |
| October 31, 2021 | 89.78% |
| September 30, 2021 | 90.44% |
| August 31, 2021 | 93.11% |
| July 31, 2021 | 93.11% |
| June 30, 2021 | 93.51% |
| May 31, 2021 | 93.51% |
| April 30, 2021 | 93.51% |
| March 31, 2021 | 93.51% |
| February 28, 2021 | 93.51% |
| January 31, 2021 | 93.51% |
| December 31, 2020 | 93.51% |
| November 30, 2020 | 93.51% |
| October 31, 2020 | 93.51% |
| September 30, 2020 | 93.51% |
| August 31, 2020 | 93.51% |
| July 31, 2020 | 93.51% |
| June 30, 2020 | 93.51% |
| May 31, 2020 | 93.51% |
| April 30, 2020 | 93.51% |
| March 31, 2020 | 93.51% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
78.53%
Minimum
Mar 2023
93.51%
Maximum
May 2019
88.13%
Average
89.78%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
| AIM ImmunoTech Inc | 99.76% |
| Perspective Therapeutics Inc | 91.70% |
| Protalix BioTherapeutics Inc | 94.35% |
| Electromed Inc | 55.84% |
| Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -18.25 |
| Beta (5Y) | 0.3962 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 51.00% |
| Historical Sharpe Ratio (5Y) | -0.2713 |
| Historical Sortino (5Y) | -0.5003 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.00% |